There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
');
1: Introduction to First-Trimester Aneuploidy Screening
2: In-Depth Look at Key Markers
3. FMF Certification & Practical Application
4: Key Takeaways & Everyday Practice Tips
5.Advanced First-Trimester Screening – Practical Cases and Learning Opportunities
Wed Sep 10, 2025
SECTION 1. Introduction to First-Trimester Aneuploidy Screening.
What is first -trimester Aneuploidy screening?
What’s Included in the Screening Toolkit?
| ULTRASOUND MARKER | WHY IS IT IMPORTANT? | WHAT IS INDICATES WHEN ABNORMAL? |
| NUCHAL TRANSLUCENCY (NT) | Fluid at the back of the fetal neck | Trisomy 21, CHD, Turner Syndrome |
| Nasal Bone (NB) | Presence or absence of nasal bone | Absent NBàTrisomy 21, 18 |
| Ductus Venosus (DV)Doppler | Blood flow in the fetal venous system | Reversed A-waveàTrisomy 21, CHD |
| Tricuspid Regurgitation (TR)Intra | Assesses right heart function | TR> 60 cm/sà Trisomy 21, CHD |
| Intracranial Translucency (IT) | Fourth ventrical fluid space | Obliteration Open Spina Bifida |
PART 5: Advanced First-Trimester Screening – Practical Cases and Learning Opportunities
Having grasped the essential markers, let’s explore actual scenarios and their applications to ensure you can effectively implement this knowledge in your practice.
CASE 1: Elevated NT with Normal Other Markers – What’s the Next Step?
Situation:
At 12 weeks of gestation, NT measures 3.8mm (Above the 99th percentile
Nasal bone is visible
Ductus Venosus Doppler shows a normal A-wave
Tricuspid Valve Doppler indicates no regurgitation
No structural abnormalities detected
Your Plan of Action:
Step 1: Evaluate Risk Based on NT Measurement
An NT greater than 3.5mm indicates a high risk for aneuploidy and congenital heart disease (CHD), but with other markers being normal, the risk is mitigated.
✅ Step 2: Discuss Follow-Up Options with the Patient:
NIPT (the most reliable non-invasive test) Early fetal echocardiography at 14-16 weeks (If NT remains elevated, assess for CHD).
✅ Step 3: Keep a Close Watch on the Pregnancy
Even if fetal karyotype and anatomy scan are normal, the risk of CHD persists at 2-5% → A detailed fetal echocardiography is warranted between 18-22 weeks.
✔ Key Takeaway: An elevated NT does not necessarily indicate aneuploidy, but thorough follow-up is crucial for detecting potential heart defects.
📌 CASE 2: Missing Nasal Bone – Is It Trisomy 21 or a Normal Variation?
📝 Situation:
NT is 1.8mm (Normal range)
Nasal Bone absent at 12 weeks
Ductus Venosus Doppler shows a normal A-wave
Tricuspid Valve Doppler indicates no regurgitation
🚀 Your Plan of Action:
✅ Step 1: Re-evaluate the Image Quality
Ensure the mid-sagittal view is accurate and the transducer is aligned parallel to the nose (to avoid misinterpretation).
✅ Step 2: Consider Ethnic Background
In certain African and Asian populations, nasal bone ossification may develop later, possibly resulting in false positives.
✅ Step 3: Provide Additional Testing Options
If risk factors are present (such as maternal age or previous T-21 pregnancy) → Suggest NIPT.
If risk factors are low, schedule a follow-up scan at 14-16 weeks to reassess the nasal bone.
✔ Key Takeaway:
The absence of a nasal bone is a significant marker for Trisomy 21 but can vary by ethnicity → Always confirm with additional markers before drawing conclusions.
CASE 3: Reversed A-Wave in DV – Does This Indicate High Risk?
📝 Situation:
At 11+5 weeks, NT is measured at 2.1mm (Within normal limits)
Nasal bone is present
Ductus Venosus Doppler shows a reversed A-wave
Tricuspid Valve Doppler indicates normal function
🚀 Your Plan of Action:
✅ Step 1: Verify the Doppler Image Quality
Use a small sample gate (0.5-1mm) to prevent contamination from the hepatic vein.
✅ Step 2: Analyze Overall Risk
A reversed A-wave alone increases the risk for aneuploidy and CHD by 2-3 times, but other markers are normal.
✅ Step 3: Suggest Further Testing
First option: NIPT
If parents desire definitive results: CVS (Chorionic Villus Sampling).
✔ Key Takeaway:
A reversed A-wave in DV is a notable risk factor for aneuploidy and CHD but should be evaluated alongside other indicators.
📌 CASE 4: Severe TR + Thick NT – Are We Looking at CHD or Trisomy 21?
📝 Situation:
At 12+2 weeks, NT measures a thick 4.8mm
Nasal bone is visible
Ductus Venosus shows a reversed A-wave
Severe Tricuspid Regurgitation >80 cm/s
Four-chamber heart view reveals right atrial enlargement
🚀 Your Plan of Action:
✅ Step 1: Identify High-Risk Indicators
Severe TR combined with a reversed DV A-wave and thick NT strongly suggests CHD (such as AVSD or HLHS).
✅ Step 2: Refer for Early Echocardiography (14-16 Weeks)
Fetal heart defects may be found in 30-40% of these instances!
✅ Step 3: Explore Genetic Testing Options
High likelihood of Trisomy 21 (Down Syndrome)
Offer NIPT or CVS.
✔ Key Takeaway:
Severe TR is more indicative of congenital heart disease than aneuploidy alone.
Final Cheat Sheet for Clinical Decision Making:
| Finding | Primary Concern | Next Step
|
| Thick NT (>3.5mm) | Trisomy 21, CHD | NIPT or Fetal Echo |
| Absent Nasal Bone | Trisomy 21, 18 | Reassess at 14-16 weeks |
| Reversed A-wave (DV) | Trisomy 21, CHD | Consider NIPT |
| Tricuspid Regurgitation >60 cm/s | CHD, Trisomy 21 | Fetal Echocardiography |
| Intracranial Translucency Loss | Open Spina Bifida | Detailed Neurosonogram |

Click here to Join our Advance fetal medicine Course to further enhance your knowledge about Aneuploidy Screening from 11 to 14 Weeks